Treatment for Chronic Obstructive Pulmonary Disease (COPD)

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility
21 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether e-cigarettes can help reduce symptoms and risks for smokers with COPD.

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease (COPD)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Manual Therapy Plus Pulmonary Rehabilitation
1
E-Cigarette
1
Azithromycin

Study Objectives

2 Primary · 4 Secondary · Reporting Duration: 12 months

12 months
6-min walk distance (6MWD)
COPD Assessment Test (CAT) scores
Cigarettes per day
Lung function tests (spirometry)
Number of exacerbations
Tobacco exposure

Trial Safety

Safety Progress

1 of 3

Similar Trials

2
Manual Therapy Plus Pulmonary Rehabilitation
2
E-Cigarette
2
Azithromycin

Trial Design

0 Treatment Group

30 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,588 Previous Clinical Trials
46,945,672 Total Patients Enrolled
96 Trials studying Chronic Obstructive Pulmonary Disease (COPD)
46,320 Patients Enrolled for Chronic Obstructive Pulmonary Disease (COPD)
Milton S. Hershey Medical CenterLead Sponsor
461 Previous Clinical Trials
2,784,576 Total Patients Enrolled
1 Trials studying Chronic Obstructive Pulmonary Disease (COPD)
10 Patients Enrolled for Chronic Obstructive Pulmonary Disease (COPD)
Raghu Sinha, PhDPrincipal InvestigatorPenn State Health Hershey Medical Center
1 Previous Clinical Trials
12 Total Patients Enrolled
Rebecca Bascom, MDPrincipal InvestigatorPenn State Health Hershey Medical Center
2 Previous Clinical Trials
181 Total Patients Enrolled

Eligibility Criteria

Age 21 - 65 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have mild to moderate COPD defined as (GOLD Grade 1-2 and Groups A-B).
You are willing to use an e-cigarette to reduce your daily cigarette use to 75% of their baseline use.

Who else is applying?

What state do they live in?
Pennsylvania100.0%
How old are they?
65+100.0%
What site did they apply to?
Penn State Health Milton S. Hershey Medical Center100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top